Loading company…
MiRTeL, based in Hiroshima, develops health check systems and offers tests such as telomere and cancer risk screening.
Established in 2012 and based in Hiroshima, Japan, MiRTeL Co.LTD. researches and develops health check systems and provides public health tests. Its tests include a telomere test for disease susceptibility, a scan test for cancer risk and an intestinal flora check, aimed at early detection and preventive care. In August 2024 the company raised JPY 60 million in venture funding from Medical Net. The company is at Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in